NASDAQ · Biotechnology

CAI (CAI) Stock

$16.45 +2.17% NASDAQ: CAI Healthcare

Valuation

MetricValue
Price$16.45
Market Cap$4.65B
P/E Ratio49.96
P/B Ratio8.70
P/S Ratio5.69
EPS (TTM)$-1.90
52-Week High$42.50
52-Week Low$14.19
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE28.35%
ROA9.32%
ROCE7.79%
Gross Margin68.72%
Operating Margin15.91%
Net Margin3.75%
Debt/Equity0.73
Current Ratio7.86

Annual Financials (USD)

Metric20202022202320242025
Revenue$294.0M$258.0M$306.0M$412.0M$812.0M
Operating Profit$139.0M$-316.0M$-320.0M$-257.0M$45.0M
Net Profit$28.0M$-321.0M$-341.0M$-282.0M$-538.0M
EPS$1.55$-1.57$-1.82$-2.70$-1.90
Op Margin47.3%-122.2%-104.4%-62.4%5.6%

Balance Sheet (USD)

Metric20202022202320242025
Total Assets$2.6B$717.0M$413.0M$344.0M$1.1B
Total Liabilities$1.9B$2.4B$2.6B$2.8B$548.0M
Cash$54.0M$107.0M$56.0M$64.0M$798.0M
Borrowings$1.7B$271.0M$217.0M$424.0M$379.0M

Latest News

Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing PR Newswire · Jul 14, 2026 BofA Adjusts Price Target on Caris Life Sciences to $23 From $28 MT Newswires · Jul 13, 2026 Caris Life Sciences (CAI) Launches Caris Detect Multi-Cancer Screening Test Insider Monkey · Jul 10, 2026 Caris Life Sciences Launches Caris Detect, the World's Most Sensitive and Comprehensive Multi-Cancer Early Detection Blood Test PR Newswire · Jul 1, 2026 Is Caris Life Sciences, Inc. (CAI) Stock Positioned for Growth With AI-Driven Precision Medicine Expansion? Insider Monkey · Jun 30, 2026

Cash Flow (USD)

Metric20202022202320242025
Operating Cash Flow$277.0M$-286.0M$-276.0M$-245.0M$83.0M
Investing Cash Flow$-253.0M$-325.0M$192.0M$44.0M$-33.0M
Financing Cash Flow$-240.0M$11.0M$0$0$-19.0M
Net Cash Flow$-7.0M$-558.0M$-51.0M$8.0M$732.0M
Free Cash Flow$58.0M$-328.0M$-298.0M$-254.0M$67.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA36.80
FCF Yield2.39%
Quick Ratio7.05
Interest Coverage0.79
Return 1Y-49.19%
Return 3Y—
Return 5Y—

Ownership

Insiders Held48.51%
Institutions Held56.74%
Institutions Float Held110.18%
Institutional HolderSharesReport Date
FMR, LLC30,785,5852026-03-31
J. H. Whitney Equity Partners VI, LLC18,256,6152026-03-31
Sixth Street Partners Management Company, L.P.14,385,3992026-03-31
Coatue Management LLC9,819,9922026-03-31
Braidwell LP 8,009,4472026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABVXAbivax S.A. $136.94 +1.50% -24.37 $10.06B 0.00%
CORT $91.12 -4.45% 146.17 $9.78B 0.00%
CYTKCytokinetics, Incorporated $80.62 -0.15% -11.82 $10.03B 0.00%
HALO $81.48 -0.55% 23.58 $9.66B 0.00%
JAZZJazz Pharmaceuticals plc $258.38 +0.94% 2071.27 $16.23B 0.00%

About CAI

CAI stock trades at $16.45 with a market capitalization of $4.65B. The stock is valued at a price-to-earnings (P/E) ratio of 49.96, price-to-book of 8.70, price-to-sales of 5.69. Over the past 52 weeks the stock has ranged between $14.19 and $42.50, and currently trades 61.3% below its 52-week high.

On profitability, CAI generates a return on equity (ROE) of 28.35% — well above the market average, a sign of a high-quality business, return on capital employed of 7.79%, an operating margin of 15.91%, a net profit margin of 3.75%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides